CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
1.0800
22-نوفمبر-24 15:44:58
15 متأخرة بدقائق
الأسهم
+0.0600
+5.88%
نطاق اليوم
1.0200 - 1.0800
ISIN
N/A
المصدر
NASDAQ
-
16 أبريل 2024 06:05:00 بحسب Nasdaq GlobeNewswire
-
02 أبريل 2024 06:05:00 بحسب Nasdaq GlobeNewswire
-
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
18 مارس 2024 06:05:00 بحسب Nasdaq GlobeNewswire
-
12 مارس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
12 مارس 2024 08:45:16 بحسب NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
11 مارس 2024 11:16:48 بحسب NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
08 مارس 2024 08:45:23 بحسب NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
07 مارس 2024 08:45:03 بحسب NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
06 مارس 2024 11:23:17 بحسب NetDania Notify
-
29 فبراير 2024 06:05:00 بحسب Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07 فبراير 2024 07:00:00 بحسب Nasdaq GlobeNewswire
-
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
14 ديسمبر 2023 06:05:00 بحسب Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 نوفمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference
08 نوفمبر 2023 06:05:00 بحسب Nasdaq GlobeNewswire
-
07 نوفمبر 2023 15:20:00 بحسب Nasdaq GlobeNewswire
-
02 نوفمبر 2023 06:05:00 بحسب Nasdaq GlobeNewswire
-
Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD
01 نوفمبر 2023 06:05:00 بحسب Nasdaq GlobeNewswire
-
31 أكتوبر 2023 06:05:00 بحسب Nasdaq GlobeNewswire
-
16 أكتوبر 2023 06:05:00 بحسب Nasdaq GlobeNewswire